STOCKWELL BRENT R has a total of 15 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are HMI MEDICAL INNOVATIONS LLC, ENDOWMENT FOR RES IN HUMAN BIO and SHANDONG CHUANGXIN PHARMACEUTICAL RES AND DEV CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Computer technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Stockwell Brent R | 15 |
#2 | Varma Hemant | 3 |
#3 | Hoffstrom Benjamin | 3 |
#4 | Foley Michael A | 1 |
#5 | Sriramaratnam Rohitha | 1 |
#6 | Haggarty Stephen J | 1 |
#7 | Schreiber Stuart L | 1 |
#8 | Herman Ariel | 1 |
#9 | Mitchison Timothy J | 1 |
#10 | Kapoor Tarun M | 1 |
Publication | Filing date | Title |
---|---|---|
US2010081654A1 | Oncogenic-RAS-signal dependent lethal compounds | |
WO2009108384A2 | Compounds and compositions that cause non-apoptotic cell death and uses thereof | |
US2008311589A1 | Method of high-throughput screening of molecules and compounds for their effects on biological and chemical processes | |
US2009031435A1 | SMA Therapy and Cell Based Assay | |
US2007149543A1 | Agents For Treating Neurodegenerative Diseases | |
US2007078144A1 | Agents for treating neurodegenerative diseases | |
US2007161644A1 | Erastin analogs and uses thereof | |
US2007027164A1 | Agents for treating neurodegenerative diseases | |
WO2006081337A2 | Erastin analogues and their uses for killing cancer cells |